Literature DB >> 14517297

P27Kip1 and p21Cip1 are not required for the formation of active D cyclin-cdk4 complexes.

Tapan K Bagui1, Subhra Mohapatra, Eric Haura, W J Pledger.   

Abstract

Our studies address questions pertaining to the regulation of D cyclin-cdk4 activity, and the following results were obtained. Conditions that increased the abundance of the D cyclins also increased the abundance of enzymatically active D cyclin-cdk4 complexes in mouse embryo fibroblasts (MEFs) lacking both p27(Kip1) and p21(Cip1) (p27/p21(-/-)). Such conditions included ectopic expression of cyclin D1 and inhibition of D cyclin degradation by the proteasome inhibitor MG132. However, as determined by treatment of wild-type MEFs with MG132, maximal accumulation of D cyclin-cdk4 complexes required p27(Kip1) and p21(Cip1) and coincided with the formation of inactive D cyclin-cdk4-p27(Kip1) or -p21(Cip1) complexes. p27(Kip1) or p21(Cip1) also increased the abundance of D cyclin-cdk4 complexes and reduced amounts of cdk4 activity when ectopically expressed in p27/p21(-/-) MEFs. Lastly, increases in the stability of the D cyclins accounted for their greater abundance in wild-type MEFs than in p27/p21(-/-) MEFs. We conclude that (i) D cyclin-cdk4 complexes are formed and become active in the absence of p27(Kip1) and p21(Cip1) and (ii) p27(Kip1) and p21(Cip1) maximize the accumulation but inhibit the activity of D cyclin-cdk4 complexes. We suggest that D cyclin-cdk4 complexes are more stable when bound to p27(Kip1) or p21(Cip1) and that formation of ternary complexes also stabilizes the D cyclins.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14517297      PMCID: PMC230308          DOI: 10.1128/MCB.23.20.7285-7290.2003

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  19 in total

Review 1.  Paradigms of growth control: relation to Cdk activation.

Authors:  Nancy Olashaw; W J Pledger
Journal:  Sci STKE       Date:  2002-05-28

2.  Regulation of CDK4 activity by a novel CDK4-binding protein, p34(SEI-1).

Authors:  M Sugimoto; T Nakamura; N Ohtani; L Hampson; I N Hampson; A Shimamoto; Y Furuichi; K Okumura; S Niwa; Y Taya; E Hara
Journal:  Genes Dev       Date:  1999-11-15       Impact factor: 11.361

3.  p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest.

Authors:  K Polyak; J Y Kato; M J Solomon; C J Sherr; J Massague; J M Roberts; A Koff
Journal:  Genes Dev       Date:  1994-01       Impact factor: 11.361

4.  Definition and mapping of adenovirus 2 nuclear transcription.

Authors:  J R Nevins
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

5.  Analysis of cyclin D3-cdk4 complexes in fibroblasts expressing and lacking p27(kip1) and p21(cip1).

Authors:  T K Bagui; R J Jackson; D Agrawal; W J Pledger
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

6.  The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts.

Authors:  M Cheng; P Olivier; J A Diehl; M Fero; M F Roussel; J M Roberts; C J Sherr
Journal:  EMBO J       Date:  1999-03-15       Impact factor: 11.598

7.  Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts.

Authors:  D E Quelle; R A Ashmun; S A Shurtleff; J Y Kato; D Bar-Sagi; M F Roussel; C J Sherr
Journal:  Genes Dev       Date:  1993-08       Impact factor: 11.361

8.  Activation of cyclin D1-kinase in murine fibroblasts lacking both p21(Cip1) and p27(Kip1).

Authors:  Masataka Sugimoto; Nicholas Martin; Deepti P Wilks; Katsuyuki Tamai; Thomas J G Huot; Cristina Pantoja; Ko Okumura; Manuel Serrano; Eiji Hara
Journal:  Oncogene       Date:  2002-11-21       Impact factor: 9.867

9.  Identification and properties of an atypical catalytic subunit (p34PSK-J3/cdk4) for mammalian D type G1 cyclins.

Authors:  H Matsushime; M E Ewen; D K Strom; J Y Kato; S K Hanks; M F Roussel; C J Sherr
Journal:  Cell       Date:  1992-10-16       Impact factor: 41.582

10.  D-type cyclin-dependent kinase activity in mammalian cells.

Authors:  H Matsushime; D E Quelle; S A Shurtleff; M Shibuya; C J Sherr; J Y Kato
Journal:  Mol Cell Biol       Date:  1994-03       Impact factor: 4.272

View more
  38 in total

1.  P53-dependent antiproliferative and pro-apoptotic effects of trichostatin A (TSA) in glioblastoma cells.

Authors:  K Bajbouj; C Mawrin; R Hartig; J Schulze-Luehrmann; A Wilisch-Neumann; A Roessner; R Schneider-Stock
Journal:  J Neurooncol       Date:  2012-01-20       Impact factor: 4.130

2.  CDK4 protein is degraded by anaphase-promoting complex/cyclosome in mitosis and reaccumulates in early G1 phase to initiate a new cell cycle in HeLa cells.

Authors:  Huabo Chen; Xiaowei Xu; Guopeng Wang; Boyan Zhang; Gang Wang; Guangwei Xin; Junjun Liu; Qing Jiang; Hongyin Zhang; Chuanmao Zhang
Journal:  J Biol Chem       Date:  2017-04-26       Impact factor: 5.157

3.  TDP-43 regulates the microprocessor complex activity during in vitro neuronal differentiation.

Authors:  Valerio Di Carlo; Elena Grossi; Pietro Laneve; Mariangela Morlando; Stefano Dini Modigliani; Monica Ballarino; Irene Bozzoni; Elisa Caffarelli
Journal:  Mol Neurobiol       Date:  2013-10-11       Impact factor: 5.590

4.  Transforming activity of Fbxo7 is mediated specifically through regulation of cyclin D/cdk6.

Authors:  Heike Laman; Juan M Funes; Hongtao Ye; Stephen Henderson; Laura Galinanes-Garcia; Eiji Hara; Phillip Knowles; Neil McDonald; Chris Boshoff
Journal:  EMBO J       Date:  2005-08-11       Impact factor: 11.598

5.  Regulated activating Thr172 phosphorylation of cyclin-dependent kinase 4(CDK4): its relationship with cyclins and CDK "inhibitors".

Authors:  Laurence Bockstaele; Hugues Kooken; Frederick Libert; Sabine Paternot; Jacques E Dumont; Yvan de Launoit; Pierre P Roger; Katia Coulonval
Journal:  Mol Cell Biol       Date:  2006-07       Impact factor: 4.272

Review 6.  Role of the CDK inhibitor p27 (Kip1) in mammary development and carcinogenesis: insights from knockout mice.

Authors:  Elizabeth A Musgrove; Elizabeth A Davison; Christopher J Ormandy
Journal:  J Mammary Gland Biol Neoplasia       Date:  2004-01       Impact factor: 2.673

7.  The CDK4/CDK6 inhibitor PD0332991 paradoxically stabilizes activated cyclin D3-CDK4/6 complexes.

Authors:  Sabine Paternot; Bianca Colleoni; Xavier Bisteau; Pierre P Roger
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

8.  Myc down-regulation affects cyclin D1/cdk4 activity and induces apoptosis via Smac/Diablo pathway in an astrocytoma cell line.

Authors:  D Amendola; M De Salvo; R Marchese; C Verga Falzacappa; A Stigliano; E Carico; E Brunetti; M Moscarini; B Bucci
Journal:  Cell Prolif       Date:  2009-02       Impact factor: 6.831

9.  Genetic evidence for functional dependency of p18Ink4c on Cdk4.

Authors:  Xin-Hai Pei; Feng Bai; Tateki Tsutsui; Hiroaki Kiyokawa; Yue Xiong
Journal:  Mol Cell Biol       Date:  2004-08       Impact factor: 4.272

10.  Functions of p21 and p27 in the regenerating epithelial linings of the mouse small and large intestine.

Authors:  Yu Zheng; Wenjun Bie; Ruyan Yang; Ansu O Perekatt; Aleksandra J Poole; Angela L Tyner
Journal:  Cancer Biol Ther       Date:  2008-03-07       Impact factor: 4.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.